# Boston Scientific Corporation (BSX) — Q4-2019 Earnings Results

**Report date:** 2020-02-05 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q4-2019

## Post-Earnings Brief

### Headline

Boston Scientific Beats on EPS, Stock Down 0.61%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.46 | N/A | +1.10% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management remains focused on driving growth through innovation. They acknowledged challenges but emphasized their commitment to long-term objectives.

**Key quotes:**

> Management highlighted ongoing investments in innovation and product development.

> They expressed confidence in their long-term growth strategy despite current market challenges.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Boston Scientific's earnings report showed a slight beat on EPS, which is a positive sign for the company. However, the stock reacted negatively, declining by 0.61%. This could indicate investor caution despite the earnings beat, possibly due to the lack of revenue data and forward guidance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q4-2019_